Michael J. McGann - 10 Jan 2023 Form 3 Insider Report for Xylem Inc. (XYL)

Role
Senior Vice President
Signature
/s/ Callie Plant, by power of attorney for Michael J. McGann
Issuer symbol
XYL
Transactions as of
10 Jan 2023
Net transactions value
$0
Form type
3
Filing time
20 Jan 2023, 16:04:11 UTC
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XYL Common Stock 1,365 10 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XYL Stock Option (Right to buy) 10 Jan 2023 Common Stock 1,193 $80.66 Direct F2
holding XYL Stock Option (Right to buy) 10 Jan 2023 Common Stock 2,694 $102.23 Direct F3
holding XYL Stock Option (Right to buy) 10 Jan 2023 Common Stock 3,147 $86.76 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects restricted stock units which are scheduled to vest as follows: 236 on February 27, 2023, 202 on March 1, 2023, 207 on March 1, 2024, 238 on March 1, 2023, 238 on March 1, 2024 and 244 on March 1, 2025. Each restricted stock unit represents the right to receive one share of common stock upon vesting.
F2 1,193 options are scheduled to vest on February 27, 2023.
F3 890 options are fully vested and exercisable, 889 are scheduled to vest on March 1, 2023 and 915 are scheduled to vest on March 1, 2024.
F4 These options are scheduled to vest in one-third increments on March 1, 2023, March 1, 2024 and March 1, 2025.